Surveillance, Monitoring and Evaluation Working Group 2nd Global TB/HIV Working Group Meeting Durban, South Africa 14-16 June 2002
Surveillance Information for action Ongoing Systematic Collection, analysis, interpretation and dissemination of public health data
Surveillance What? Who? How?
What to Survey? Prevalence of HIV among TB patients Smear + Smear - Extra pulmonary TB New TB cases Re-treatment
How to Survey HIV among TB? Systematic Regular Collaborative HIV anonymous Part of national HIV surveillance Revisit WHO/IUATLD guidelines
What to Survey? TB among HIV infected people Important for monitoring epidemic trend and intervention impact
How to Survey TB Among HIV? Long term: establish a national anonymous HIV reporting system including AIDS indicator diseases Short term: cohort studies
Who Should do the Surveillance? Joint activity between the NAP and the NTP
Surveillance: Other Points Quality assurance Data feedback to service providers Monitoring possible relation between HIV and MDR-TB
Monitoring and Evaluation Monitoring X Evaluation Monitoring activities Evaluating outcomes Guidelines: comprehensive set of indicators Local prioritisation required Review standardized data collection tool Indicators should link to overall objectives and goals
Monitoring and Evaluation Targets Aspirational targets: difficult but inevitable Outcome (impact on TB/HIV) Operational targets Measurable Level specific: district/national/international Informed by modelling
Monitoring and Evaluation Monitoring X Evaluation Monitoring activities Evaluating outcomes Guidelines: comprehensive set of indicators Local prioritisation required